Characteristics of the epidemic process of measles, rubella and mumps and assessment of their seroprevalence at the present stage
Problems of Virology · 2025
DOI: 10.36233/0507-4088-282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Problems of Virology, 2025. Verfasst von Y V Simakova und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Research Centre for Epidemiology and Microbiology Named After Honorary Academician N. F. Gamaleya of the Ministry of Health of the Russian F…. Hauptthemen laut MEDLINE: Measles, Mumps, Rubella, Antibodies, Viral. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The problem of vaccine-preventable infections requires assessing the state of herd immunity through serological monitoring. The aim. To study the epidemiological features of measles, rubella and mumps and to estimate their seroprevalence in the last decade in Moscow. Materials and methods. Forms of federal statistical observation; State reports «On the state of sanitary and epidemiological well-being of the Moscow population»; official EMISS data for 2012–2023 were used to conduct a retrospective analysis of incidence. Blood serum samples (n = 7458) from healthy individuals stratified by age were tested for the presence of IgG antobodies to measles, rubella and mumps using the ELISA. Statistical data processing was performed using Microsoft Excel and SPSS Statistics v.27 (IBM).
Results
The analysis of epidemiological situation in Moscow in 2012–2023 revealed the presence of multidirectional trends: wave-like increase in the incidence of measles, stabilization of rubella cases registration and unstable incidence of mumps with an upward trend. A high prevalence of IgG antibodies to rubella virus was determined, preventing the spread of infection among the population. The formed level of herd immunity to mumps does not allow reducing the incidence to sporadic cases. The observed trend of increasing measles incidence can be explained by the accumulation of non-immune individuals among the population.
Conclusion
The significant proportion of seronegative individuals indicate the necessity to adjust vaccination prevention tactics and implement measures for mopping-up and catch-up immunization of the population against measles and mumps, especially in risk age groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Research Centre for Epidemiology and Microbiology Named After Honorary Academician N. F. Gamaleya of the Ministry of Health of the Russian Federation.
- I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University).
- Lomonosov Moscow State University.
- Novosibirsk State University.
- National Medical Research Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation.
ORCID-Profile: Y V Simakova, V A Gushchin, T A Semenenko, D A Ogarkova, D A Kleymenov, A V Nozdracheva, V A Manuylov, A P Tkachuk, A L Gintsburg
Zitieren
APA
Simakova, Y. V., Gushchin, V. A., Semenenko, T. A., Ogarkova, D. A., Kleymenov, D. A., Nozdracheva, A. V., Manuylov, V. A., Tkachuk, A. P., & Gintsburg, A. L. (2025). Characteristics of the epidemic process of measles, rubella and mumps and assessment of their seroprevalence at the present stage. Problems of Virology. https://doi.org/10.36233/0507-4088-282
Vancouver
Simakova YV, Gushchin VA, Semenenko TA, Ogarkova DA, Kleymenov DA, Nozdracheva AV, et al. Characteristics of the epidemic process of measles, rubella and mumps and assessment of their seroprevalence at the present stage. Problems of Virology. 2025. doi:10.36233/0507-4088-282
BibTeX
@article{Simakova2025,
author = {Simakova, Y V and Gushchin, V A and Semenenko, T A and Ogarkova, D A and Kleymenov, D A and Nozdracheva, A V and Manuylov, V A and Tkachuk, A P and Gintsburg, A L},
title = {Characteristics of the epidemic process of measles, rubella and mumps and assessment of their seroprevalence at the present stage},
journal = {Problems of Virology},
year = {2025},
doi = {10.36233/0507-4088-282}
}
EUVIMED